Mast Therapeutics, Inc. (MSTX) - NYSEMKT
  • BestPick | Send Message 21 Jun

    $MSTX soon, 2nd week of July release? or end of June, maybe? worth to hold and see. Good luck~
    Reply
      • Slingshot Insights | Send Message 16 Jun

        This Week In Pharma: Manufacturing Woes For AstraZeneca's ZS-9 And Mast's EPIC Delay $AZN, $MSTX http://seekingalpha.com/a/2dcu5
        Reply
          • timtrading | Send Message 14 Jun
            Reply
              • BestPick | Send Message 7 Jun

                $MSTX added here @.38 good luck
                Reply
                  • sabio | Send Message 6 Jun
                    Reply
                      • Colin Macleod | Send Message 2 Jun

                        $MSTX - Mast Therapeutics Inc - Independent Analysis Video http://bit.ly/1VAmQfJ
                        Reply
                          • timtrading | Send Message 1 Jun
                            Reply
                              • joelkatz | Send Message 27 May

                                $MSTX is holding tight, it can't decide yet which route to go
                                Reply
                                  • N.O.C. | Send Message 16 May

                                    Great news on $MSTX this AM: http://tinyurl.com/zkczs6t
                                    Reply
                                      • SlimmyHendrix | Send Message 18 Apr

                                        $MSTX starting that PH3 trials news run up. Might get a pop over $.60 on good news
                                        Reply (2)
                                        • Smario | Send Message 21 Apr
                                          : over $2.00 at least
                                        • BestPick | Send Message 25 Apr
                                          : .60 cent is a joke, at least $2 is more likely
                                          Company Description
                                          Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It provides products MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States